F-FDG PET/CT revealed sporadic schwannomatosis involving the lumbar spinal canal and both lower limbs: a case report.

Xiaotian Li, Xianwen Hu, Pan Wang, Jiong Cai
Author Information
  1. Xiaotian Li: Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  2. Xianwen Hu: Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  3. Pan Wang: Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  4. Jiong Cai: Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Abstract

Schwannomatosis is a rare autosomal dominant hereditary syndrome disease characterized by multiple schwannomas throughout the body, without bilateral vestibular schwannoma or dermal schwannoma. The most common location of schwannomatosis is the head and neck, as well as the limbs, while multiple schwannomas in the lumbosacral canal and lower extremities are relatively rare. In this study, we report a 79-year-old woman diagnosed with schwannomatosis. MRI and contrast-enhanced imaging revealed multiple schwannomas in both lower extremities. An F-FDG PET/CT examination revealed that in addition to multiple tumors with increased F-FDG uptake in both lower extremities, there was also an increased F-FDG uptake in a mass in the lumbosacral canal. These masses were confirmed to be schwannomas by pathology after surgery or biopsy. F-FDG PET/CT findings of schwannomas were correlated with MRI and pathological components. Antoni A area rich in tumor cells showed significant enhancement on contrast-enhanced T1WI, and PET/CT showed increased uptake of F-FDG in the corresponding area, while Antoni B region rich in mucus showed low enhancement on contrast-enhanced T1WI, accompanied by a mildly increased F-FDG uptake.

Keywords

References

  1. Oncologist. 2012;17(10):1317-22 [PMID: 22927469]
  2. Clin Neuropathol. 2016 Mar-Apr;35(2):78-83 [PMID: 26709712]
  3. Int J Mol Sci. 2021 May 29;22(11): [PMID: 34072574]
  4. Acta Radiol. 2012 Dec 1;53(10):1137-41 [PMID: 23081955]
  5. World Neurosurg. 2019 Mar;123:318-322 [PMID: 30576819]
  6. Surg Radiol Anat. 2023 Dec;45(12):1599-1602 [PMID: 37878067]
  7. Hum Mutat. 2008 Feb;29(2):227-31 [PMID: 18072270]
  8. Neuro Oncol. 2023 Dec 8;25(12):2237-2238 [PMID: 37715980]
  9. Neurosurgery. 2021 Feb 16;88(3):443-456 [PMID: 33588442]
  10. Front Oncol. 2023 Oct 30;13:1258769 [PMID: 37965461]
  11. J Bone Joint Surg Br. 2007 Mar;89(3):382-7 [PMID: 17356155]
  12. Sci Rep. 2023 Oct 16;13(1):17568 [PMID: 37845257]
  13. Genet Med. 2022 Sep;24(9):1967-1977 [PMID: 35674741]
  14. Ear Nose Throat J. 2023 Jan 4;:1455613221145803 [PMID: 36597949]
  15. Br J Neurosurg. 2022 Apr;36(2):171-174 [PMID: 33263426]
  16. AJNR Am J Neuroradiol. 2007 Oct;28(9):1633-8 [PMID: 17893219]
  17. Skeletal Radiol. 2023 Mar;52(3):405-419 [PMID: 35713690]
  18. Am J Med Genet A. 2022 Sep;188(9):2672-2683 [PMID: 35678462]
  19. Nat Genet. 2014 Feb;46(2):182-7 [PMID: 24362817]
  20. Neurology. 2005 Jun 14;64(11):1838-45 [PMID: 15955931]
  21. J Clin Pathol. 2016 Jun;69(6):484-9 [PMID: 26941181]
  22. Radiographics. 2022 Jul-Aug;42(4):1123-1144 [PMID: 35749292]
  23. Neurology. 2017 Jan 3;88(1):87-92 [PMID: 27856782]
  24. Eur J Radiol. 2021 Aug;141:109820 [PMID: 34139574]
  25. Diagn Pathol. 2023 Oct 13;18(1):112 [PMID: 37833805]
  26. Brain. 2013 Feb;136(Pt 2):549-63 [PMID: 23413263]
  27. Neurogenetics. 2012 May;13(2):141-5 [PMID: 22434358]
  28. Expert Rev Neurother. 2018 Jan;18(1):29-39 [PMID: 29088993]
  29. Pathol Oncol Res. 2019 Oct;25(4):1667-1670 [PMID: 29740763]
  30. AJR Am J Roentgenol. 2016 Dec;207(6):1288-1296 [PMID: 27657364]
  31. Neurosurg Clin N Am. 2004 Apr;15(2):145-55 [PMID: 15177314]
  32. Semin Diagn Pathol. 2021 May;38(3):167-174 [PMID: 33762087]
  33. Eur J Nucl Med. 2001 Oct;28(10):1541-51 [PMID: 11685498]
  34. Nat Commun. 2023 Jul 6;14(1):4003 [PMID: 37414763]
  35. Hered Cancer Clin Pract. 2022 Jun 13;20(1):23 [PMID: 35698239]
  36. Neuro Oncol. 2016 May;18(5):624-38 [PMID: 26851632]
  37. Neurosurg Clin N Am. 2004 Apr;15(2):167-75, vi [PMID: 15177316]
  38. Chin Med J (Engl). 2013 Jul;126(14):2656-60 [PMID: 23876891]
  39. Curr Oncol. 2022 Jul 09;29(7):4842-4855 [PMID: 35877244]

Word Cloud

Created with Highcharts 10.0.0F-FDGschwannomasPET/CTmultipleschwannomatosislowerincreaseduptakeschwannomacanalextremitiescontrast-enhancedrevealedshowedrarelumbosacralreportMRIAntoniarearichenhancementT1WISchwannomatosisautosomaldominanthereditarysyndromediseasecharacterizedthroughoutbodywithoutbilateralvestibulardermalcommonlocationheadneckwelllimbsrelativelystudy79-year-oldwomandiagnosedimagingexaminationadditiontumorsalsomassmassesconfirmedpathologysurgerybiopsyfindingscorrelatedpathologicalcomponentstumorcellssignificantcorrespondingBregionmucuslowaccompaniedmildlysporadicinvolvinglumbarspinallimbs:case18F-FDGneurofibromatosis

Similar Articles

Cited By